Skip to main content

H.R. 3130

Referred to Committee

FACTS Act

Introduced 5/1/2025•119th Congress•House

Latest Action

Referred to the Committee on Education and Workforce, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

5/1/2025 • House

Summary

Fentanyl Awareness for Children and Teens in Schools Act or the FACTS Act

This bill establishes grant programs and requires strategies and studies to address the misuse of synthetic opioids (i.e., laboratory-derived substances such as fentanyl and its derivatives) among youth.

The bill requires the Department of Health and Human Services (HHS) to award grants to partnerships between educational and health organizations for prevention, treatment, and recovery efforts related to the use of synthetic opioids by middle and high school-aged children. It also allows school-based health centers to use existing HHS grants to purchase naloxone to reverse the effects of opioid overdoses and to establish programs to address misuse of synthetic opioids.  

Also, the bill authorizes state educational agencies to use certain Department of Education (ED) grant funds to provide training to school personnel on addressing students’ misuse of synthetic opioids. State and local educational agencies must also address such misuse in their educational plans in order to qualify for certain ED grants.

Finally, the bill (1) establishes an interagency taskforce to coordinate federal efforts to address synthetic opioid misuse among youth, (2) requires an evaluation of the State Unintentional Drug Overdose Reporting System’s effectiveness in identifying the specific synthetic opioids causing youth overdoses, (3) expands the data reported by the National Center for Education Statistics to include information about the use of synthetic opioids in schools, and (4) requires two recurring HHS surveys to include questions on youth exposure to synthetic opioids.    

Introduced in House • 5/1/2025

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (10)

Party Breakdown

5
Democrats
5
Republicans
0
Independents

Sponsor

R[
Rep. Bonamici, Suzanne [D-OR-1]

Democrat • OR-1

Sponsored 5/1/2025

Cosponsors (9)

R[
R[
Rep. Neguse, Joe [D-CO-2]

D-CO-2

Joined 5/1/2025

R[
R[
R[
Rep. Craig, Angie [D-MN-2]

D-MN-2

Joined 9/16/2025

R[
Rep. Nunn, Zachary [R-IA-3]

R-IA-3

Joined 10/17/2025

Bill Journey

Originated in the House

Introduced

May 1, 2025

Referred to the Committee on Education and Workforce, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House5/1/2025

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors9